Verséa Ophthalmics will distribute Celularity’s Biovance and Biovance 3L Ocular products for ocular surface disease treatment and ocular surgical support under the terms of an exclusive U.S. commercialization agreement.
Biovance and Biovance 3L Ocular are single-layer and three-layer allografts, respectively, designed to be used as a biological membrane covering, according to a press release. In addition, Biovance 3L Ocular protects underlying tissue and preserves tissue plane boundaries.
Product applications include corneal and conjunctival-related injuries or defects, including